In the wake of recent breakthroughs in antiviral therapies and Centers
for Disease Control and Prevention (CDC) recommendations advocating occupational
postexposure prophylaxis (PEP), health care workers are increasingly receiving
inquiries about PEP following exposures to the human immunodeficiency virus
(HIV) through sex and injection drug use. The probability of HIV transmission
by certain sexual or injection drug exposures is of the same order of magnitude
as percutaneous occupational exposures for which the CDC recommends PEP. In
such cases, if the exposure is sporadic, it seems appropriate to extrapolate
from the data on occupational PEP and recommend prophylaxis. However, for
individuals with continuing or low-risk exposures, we instead recommend referrals
to state-of-the-art risk reduction programs. Clinicians, using local HIV seroprevalence
data and their knowledge of transmission probabilities, can help exposed patients
make an informed decision regarding PEP. Because of the large number of risky
encounters that will not be treated prophylactically, even after significant
outreach efforts, public health interventions that emphasize PEP as part of
a comprehensive HIV prevention program should be confined to cities with highest
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 56
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
For example, a trial of intravenous immunoglobulin in advanced human immunodeficiency infection...
The Rational Clinical Examination
Evidence Summary and Review 3
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.